Showing results (301-310 of 323) with videos related to

Sort By:
Pageof 33
Frontiers in Pharmacology|May 8, 2023
The calcium-sensing receptor modulates the prostaglandin E<sub>2</sub> pathway in intestinal inflammationValeriya Gushchina, Nadja Kupper, Michael Schwarzkopf, et al.
The Lancet. Haematology|November 29, 2023
Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trialJong Wook Lee, Morag Griffin, Jin Seok Kim, et al.
Blood|December 19, 2024
Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVHAustin Kulasekararaj, Morag Griffin, Caroline Piatek, et al.
The Journal of Infectious Diseases|March 30, 2012
Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosisMarco Schito, Trevor F Peter, Sean Cavanaugh, et al.
Urologic Oncology|March 20, 2024
The assessment of bladder cancer resectability with bimanual palpation: A prospective study in laparoscopy and open cystectomy patientsAnna K Czech, Katarzyna Gronostaj, Jakub Frydrych, et al.
The Journal of Cardiovascular Surgery|December 11, 2023
Endovascular carotid revascularization under open-chest extracorporeal circulation combined with cardiac surgery in unstable patients at increased risk of carotid-related stroke: SIMultaneous urgent cardiac surgery and MicroNet-covered stent carotid revascularization in extreme-risk patients-SIMGUARD StudyKarolina Dzierwa, Anna Kedziora, Lukasz Tekieli, et al.
Science (New York, N.Y.)|June 16, 2012
Dipolar antiferromagnetism and quantum criticality in LiErF₄Conradin Kraemer, Neda Nikseresht, Julian O Piatek, et al.
Annals of Hematology|January 22, 2025
Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuriaAustin Kulasekararaj, Robert Brodsky, Hubert Schrezenmeier, et al.
Applied and Environmental Microbiology|February 25, 2018
Genus-Wide Assessment of Lignocellulose Utilization in the Extremely Thermophilic Genus Caldicellulosiruptor by Genomic, Pangenomic, and Metagenomic AnalysesLaura L Lee, Sara E Blumer-Schuette, Javier A Izquierdo, et al.
European Journal of Haematology|December 10, 2020
One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumabAustin G Kulasekararaj, Anita Hill, Saskia Langemeijer, et al.
Pageof 33